Galactose

Galactose

SCHEMBL361095

O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO.O=P(O)(O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Galactose. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
TDP1 Q9NUW8 1/20 0.46
MPI P34949 1/20 0.44
PDE4A P27815 1/20 0.40
USP2 O75604 1/20 0.38
SLCO1B1 Q9Y6L6 1/20 0.38
AKR1B1 P15121 1/20 0.37
KDM4E B2RXH2 2/20 0.35
CYP2C19 P33261 1/20 0.30
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Demannose SCHEMBL30973585 1.00 LMNA (0.48) LMNAL3MBTL1TDP1MPIPDE4A
Demannose SCHEMBL3397670 1.00 LMNA (0.48) LMNAL3MBTL1TDP1MPIPDE4A
Demannose SCHEMBL361547 1.00 LMNA (0.48) LMNAL3MBTL1TDP1MPIPDE4A
Demannose SCHEMBL31755099 1.00 LMNA (0.48) LMNAL3MBTL1TDP1MPIPDE4A
Demannose SCHEMBL23721809 1.00 LMNA (0.48) LMNAL3MBTL1TDP1MPIPDE4A
Demannose SCHEMBL285569 1.00 LMNA (0.48) LMNAL3MBTL1TDP1MPIPDE4A
Demannose SCHEMBL25380809 1.00 LMNA (0.48) LMNAL3MBTL1TDP1MPIPDE4A
Demannose SCHEMBL6533561 1.00 LMNA (0.48) LMNAL3MBTL1TDP1MPIPDE4A
Demannose SCHEMBL25381696 1.00 LMNA (0.48) LMNAL3MBTL1TDP1MPIPDE4A
Demannose SCHEMBL30572907 1.00 LMNA (0.48) LMNAL3MBTL1TDP1MPIPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020198874-A1 CANNABIDIOLIC ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF SCF PHARMA INC. (CA) 2020-10-08 WO claimed
EP-2593549-A2 METABOLICALLY ENGINEERED ORGANISMS FOR THE PRODUCTION OF ADDED VALUE BIO-PRODUCTS Universiteit Gent (BE) 2013-05-22 EP claimed
WO-2012007481-A2 METABOLICALLY ENGINEERED ORGANISMS FOR THE PRODUCTION OF ADDED VALUE BIO-PRODUCTS UNIVERSITEIT GENT (BE) 2012-01-19 WO claimed
EP-2136844-A1 COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF Centre De Recherche Sur Les Biotechnologies Marine (CA) 2009-12-30 EP claimed
EP-2121576-A1 POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF Centre De Recherche Sur Les Biotechnologies Marine (CA) 2009-11-25 EP claimed
WO-2008113177-A1 COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) 2008-09-25 WO claimed
WO-2008098375-A1 POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) 2008-08-21 WO claimed
JP-10195094-A None JP disclosed
EP-4739700-A1 RESPIRATORY SYNCYTIAL VIRUS MUTANTS, FUSION PEPTIDES, PARTICLES, NUCLEIC ACIDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE Emory University (US) 2026-05-13 EP disclosed
EP-4731778-A2 SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES Inbiose N.V. (BE) 2026-04-29 EP disclosed
EP-4702138-A1 PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL Inbiose N.V. (BE) 2026-03-04 EP disclosed
EP-4662224-A1 PRODUCTION OF A SACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF LACTOBIONIC ACID Inbiose N.V. (BE) 2025-12-17 EP disclosed
EP-4662305-A1 PRODUCTION OF A DISACCHARIDE AND/OR MILK OLIGOSACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF UDP-GLCNAC Inbiose N.V. (BE) 2025-12-17 EP disclosed
EP-1360299-A2 THE GENOME OF A BIFIDOBACTERIUM SOCIETE DES PRODUITS NESTLE S.A. (CH) 2003-11-12 EP disclosed
US-6645725-B2 Detecting autoantibody reactivity with Thomsen-Friedenreich antigen; increased levels are indicative oof endometriosis RESEARCH CORPORATION TECHNOLOGIES, INC. 2003-11-11 US disclosed
US-20030130798-A1 Multiparameter integration methods for the analysis of biological networks THE INSTITUTE FOR SYSTEMS BIOLOGY 2003-07-10 US disclosed
WO-2002074798-A2 THE GENOME OF A BIFIDOBACTERIUM SOCIETE DES PRODUITS NESTLE S.A. (CH) 2002-09-26 WO disclosed
WO-2002055723-A1 GLYCOCONJUGATE AND SUGAR NUCLEOTIDE SYNTHESIS USING SOLID SUPPORTS WAYNE STATE UNIVERSITY (US) 2002-07-18 WO disclosed
JP-H10195094-A NEW SULFATED OR PHOSPHATED GALACTOSE DERIVATIVE AND ITS PRODUCTION SANWA KAGAKU KENKYUSHO CO LTD 1998-07-28 JP disclosed
EP-0086535-A1 Photosensitive compositions and products EVREKA, INC. (US) 1983-08-24 EP disclosed